Cervical Cancer Screening (Pap Smear) Age Requirements and Frequency
Women should begin cervical cancer screening at age 21 regardless of sexual history, with screening every 3 years using cytology (Pap smear) alone until age 30, and then either continue cytology every 3 years or switch to co-testing (cytology plus HPV testing) every 5 years until age 65. 1
Initial Screening Age
- Begin screening at age 21 regardless of when sexual activity began 2, 1
- Previous recommendations to begin screening within 3 years of first sexual intercourse have been replaced by the age-based recommendation 2
- Starting screening before age 21 is not recommended due to:
Screening Frequency by Age Group
Ages 21-29:
- Screen every 3 years with cytology (Pap smear) alone 2, 1
- HPV testing is not recommended in this age group 1
Ages 30-65:
- Option 1: Continue screening every 3 years with cytology alone 2, 1
- Option 2: Screen every 5 years with co-testing (cytology plus HPV testing) 2, 1
- Women who have had 3 consecutive negative Pap tests may be screened less frequently 2
When to Stop Screening
Women can discontinue screening at age 65 if they have had:
Women should continue screening beyond age 65 if they have:
- A history of cervical cancer
- High-grade precancerous lesions
- In utero DES exposure
- Immunocompromised status 1
Special Circumstances
After Hysterectomy:
- Women who have had a total hysterectomy (with removal of the cervix) for benign reasons and no history of high-grade precancerous lesions should discontinue screening 2, 1
- Women who have had a subtotal hysterectomy (cervix remains) should continue age-appropriate screening 1
Women with History of Abnormal Results:
- Women with a history of CIN2/3 should continue screening until they have three consecutive negative Pap tests with no abnormal results within a 10-year period 1
- Women with previous abnormal results are more likely to undergo more frequent screening (80% undergo annual screening) 3
Common Pitfalls to Avoid
Overscreening: Despite guidelines recommending less frequent screening, studies show that 55% of American women undergo annual Pap screening 3. This leads to unnecessary procedures, increased healthcare costs, and potential psychological harm.
Underscreening: About 11% of women are not being screened regularly 3. Ensure that all eligible women receive appropriate screening.
Screening too early: Beginning screening before age 21 is not recommended regardless of sexual activity onset 1.
Continuing screening unnecessarily: Screening women who have had a total hysterectomy for benign disease or women over 65 with adequate prior negative screening provides minimal benefit while exposing them to potential harms 1.
Stopping screening prematurely: Never discontinue screening before age 65 in average-risk women without verifying adequate prior screening 1.
By following these evidence-based guidelines, clinicians can optimize the benefits of cervical cancer screening while minimizing potential harms to patients.